HomeNewsMassachusetts Retail Marijuana Sales Reach Record High

Massachusetts Retail Marijuana Sales Reach Record High

Adult-use marijuana retailer sales in Massachusetts hit a new high in June, while medical marijuana sales in the state stagnate.

According to information from the state’s Cannabis Control Commission, retail sales reached $132.8 million in June 2023. The gross sales total since adult use retailers opened in late 2018 to early this month is pegged at a whopping $4.74 billion.

The cost of adult-use cannabis in Massachusetts has dropped significantly over the years. In January 2020, the average retail cost of flower per gram  was $14.69. In June 2023, it was just $5.82, a new record low.

As for medicinal marijuana purchased through treatment centers, there were $19 million in sales last month; the second lowest monthly result so far this year. The highest monthly total was back in March 20 21 – $27.7 million. Treatment center sales to patients and caregivers since March 2019 is estimated at $1.08 billion.

In states where recreational sales are permitted, it’s not unusual for this to negatively impact on medical sales as consumers often consider the retail route a relatively hassle-free option with better access to products. But there can be advantages under medical programs. In Massachusetts, adult-use marijuana is subject to various taxes:

  • A state sales tax of 6.25%
  • A state excise tax of 10.75%
  • A local option tax for cities or towns: up to 3%

The sale of medical-use marijuana is not subject to tax in Massachusetts, assuming patients present their program ID Card and valid government-issued identification at the time of sale.

Massachusetts law also allows for registered medical marijuana patients to home-grow up to twelve flowering and twelve vegetative cannabis plants. Adult-use consumers can also home-grow, but are limited to no more than 6 cannabis plants or up to 12 plants for two or more adults.

However, Massachusetts’ medical program is rather restrictive in terms of qualifying conditions; which are Amyotrophic Lateral Sclerosis (ALS), cancer, Crohn’s disease, glaucoma, HIV/AIDS, Hepatitis C, Multiple Sclerosis and Parkinson’s disease.

Further information on the state’s medical and adult-use programs can be found on the Cannabis Control Commission’s website.

Gillian Jalimnson
Gillian Jalimnson is one of Hemp Gazette's staff writers and has been with us since we kicked off in 2015. Gillian sees massive potential for cannabis in areas of health, energy, building and personal care products and is intrigued by the potential for cannabidiol (CBD) as an alternative to conventional treatments. You can contact Gillian here.

Most Popular